# Lipofer (Iron Pyrophosphate)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lipofer
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Ferric pyrophosphate, Iron(III) pyrophosphate, Fe₄(P₂O₇)₃, Microencapsulated ferric pyrophosphate, Micronized iron pyrophosphate, Iron pyrophosphate liposomal, Encapsulated iron pyrophosphate

## Overview

Lipofer is a microencapsulated iron pyrophosphate ingredient developed by Indena, in which ferric iron is encapsulated in a phospholipid matrix to improve mucosal uptake via intestinal absorption pathways. This delivery system is designed to reduce the oxidative reactivity of free ionic iron, theoretically lowering gastrointestinal irritation while maintaining bioavailability comparable to or exceeding standard ferric pyrophosphate.

## Health Benefits

• Iron deficiency treatment with reduced gastrointestinal side effects compared to free iron (manufacturer claims, no clinical trials provided)
• Enhanced iron absorption showing 3.5x higher bioavailability than standard ferric pyrophosphate (animal study referenced, study design not specified)
• No metallic taste or pro-oxidative activity detected (technical reports, human evidence not available)
• Better dispersibility in food matrices for fortification purposes (technical specifications only)
• Potentially improved iron storage through enhanced transferrin-to-ferritin transfer mechanisms (mechanistic data only, no clinical validation)

## Mechanism of Action

Lipofer delivers ferric iron (Fe³⁺) encapsulated within a phospholipid bilayer, which facilitates uptake across intestinal epithelial cells by protecting the iron from luminal pH fluctuations and reducing pro-oxidant interactions with gut mucosa. Once absorbed, ferric iron is reduced to ferrous iron (Fe²⁺) by duodenal cytochrome b (Dcytb) reductase, enabling transport via divalent metal transporter 1 (DMT1) into enterocytes. Iron then enters systemic circulation bound to transferrin, where it is utilized for hemoglobin synthesis and cellular metabolic functions.

## Clinical Summary

Evidence for Lipofer's efficacy is currently limited; manufacturer-cited data reference an animal study suggesting approximately 3.5-fold higher bioavailability than standard ferric pyrophosphate, but the study design, species, and sample size have not been publicly disclosed in peer-reviewed literature. No published randomized controlled trials in human subjects have been identified as of the available data, meaning claims of reduced gastrointestinal side effects relative to ferrous sulfate or ferric salts remain manufacturer-level assertions rather than clinically validated findings. The broader class of microencapsulated iron compounds has shown promise in food fortification contexts, but Lipofer-specific human pharmacokinetic data are lacking. Consumers and clinicians should treat efficacy and tolerability claims with caution pending robust human trial data.

## Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable"}, "micronutrients": {"iron": {"compound": "Iron Pyrophosphate", "approximate_concentration": "Varies by formulation, typically around 10-20 mg per serving", "bioavailability": "Enhanced absorption with 3.5x higher bioavailability than standard ferric pyrophosphate"}}, "bioactive_compounds": {"pro-oxidative_activity": "None detected"}, "vitamins": "Not applicable"}

## Dosage & Preparation

No clinically studied dosage ranges for Lipofer are available from human trials. Technical reports indicate it contains approximately 8.12% elemental iron in liposomal variants, supplied as a fine, dispersible powder for food fortification. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Iron supplementation in general is contraindicated in individuals with hemochromatosis, hemosiderosis, or other iron overload disorders, and Lipofer carries the same contraindication profile as other iron-containing supplements. Common iron-related side effects including constipation, nausea, and dark stools may theoretically be reduced with the microencapsulated form, but this has not been confirmed in controlled human trials. Iron can inhibit the absorption of quinolone and tetracycline antibiotics, levothyroxine, and bisphosphonates when taken concurrently; a minimum two-hour separation is generally recommended. Pregnancy safety follows standard iron supplementation guidance — iron is essential during pregnancy, but dosing should be supervised by a healthcare provider to avoid excess, and pediatric dosing requires careful weight-based calculation to prevent toxicity.

## Scientific Research

The research dossier reveals no human clinical trials, RCTs, or meta-analyses specifically for Lipofer, with no PubMed PMIDs provided. Available evidence consists of manufacturer technical reports referencing one CSIC animal study showing 3.5x better bioavailability than ferric pyrophosphate and 2.7x better than ferrous sulfate, though study design and sample size were not specified.

## Historical & Cultural Context

No historical or traditional medicinal use is documented for Lipofer or ferric pyrophosphate, as it is a modern synthetic compound developed specifically for iron fortification without roots in traditional medicine systems.

## Synergistic Combinations

Vitamin C, B12, Folate, Copper, Vitamin A

## Frequently Asked Questions

### What is Lipofer and how is it different from regular iron supplements?

Lipofer is a branded microencapsulated iron pyrophosphate ingredient made by Indena, in which ferric iron (Fe³⁺) is coated in a phospholipid matrix. Unlike free ferrous sulfate or ferric salts, this encapsulation is intended to shield the gastrointestinal lining from direct iron contact, potentially reducing irritation and oxidative stress in the gut, though human clinical trials confirming this advantage are not yet publicly available.

### Is Lipofer better absorbed than standard ferric pyrophosphate?

An animal study cited by the manufacturer suggests Lipofer has approximately 3.5 times higher bioavailability than standard ferric pyrophosphate, attributed to its phospholipid encapsulation improving mucosal uptake. However, the specific study design, animal model, and sample size have not been disclosed in peer-reviewed publications, so this figure should be interpreted cautiously until human pharmacokinetic data are available.

### Does Lipofer cause constipation or stomach upset?

Manufacturer claims suggest that the microencapsulation of iron in Lipofer reduces direct contact between reactive ferric iron and intestinal mucosa, which theoretically lowers the risk of constipation, nausea, and stomach cramping compared to conventional iron salts like ferrous sulfate. However, no published controlled human trials have directly compared gastrointestinal tolerability of Lipofer to standard iron supplements, so this benefit remains unconfirmed at the clinical level.

### What is the recommended dosage of Lipofer for iron deficiency?

No standardized clinical dosage for Lipofer specifically has been established in peer-reviewed human trials. General adult supplemental iron dosing for iron deficiency anemia typically ranges from 100–200 mg of elemental iron daily when using conventional salts, but microencapsulated forms may have different elemental iron content per dose. Dosing of Lipofer-containing products should follow the product label and be confirmed with a healthcare provider based on serum ferritin and hemoglobin levels.

### Can Lipofer be taken with other medications?

Like all iron supplements, Lipofer has the potential to reduce the absorption of several medications when taken simultaneously, including quinolone antibiotics (e.g., ciprofloxacin), tetracyclines, levothyroxine, and bisphosphonates such as alendronate. A separation of at least two hours before or four hours after taking these medications is generally recommended. Additionally, calcium, antacids, and proton pump inhibitors can reduce iron absorption, so timing of Lipofer intake relative to these agents should be discussed with a pharmacist or physician.

### What is the evidence quality for Lipofer's bioavailability claims?

Lipofer's bioavailability advantage is primarily supported by animal studies with unspecified study designs, rather than human clinical trials. While manufacturer technical reports claim 3.5x higher bioavailability than standard ferric pyrophosphate and absence of pro-oxidative activity, independent peer-reviewed human studies validating these claims are not currently available. When evaluating Lipofer, it is important to distinguish between manufacturer-sponsored technical data and rigorous clinical evidence in human populations.

### Who should consider Lipofer supplementation versus other iron forms?

Lipofer may be most relevant for individuals who experience gastrointestinal side effects with standard iron supplements, since manufacturer claims suggest reduced stomach upset compared to free iron sources. However, those with confirmed iron deficiency anemia should verify that their healthcare provider has evaluated which iron form is appropriate for their specific condition. People with iron absorption disorders or those taking medications that affect iron bioavailability should consult a healthcare professional before choosing Lipofer over other established iron supplements.

### Does Lipofer have any reported taste or sensory issues compared to other iron supplements?

According to technical reports, Lipofer does not produce the metallic taste commonly associated with some iron supplements, which may improve compliance and tolerability. However, human sensory or tolerability studies comparing Lipofer directly to other iron forms in actual supplement users have not been published. This absence of reported metallic taste is a potential practical advantage, though individual experiences may vary depending on formulation and dosage.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*